A Multi-Led Source for Photoradiation Therapy

  • Giulio Jori
  • Riccardo Pratesi
  • M. Scalvini


Light sources emitting at the long wavelength wing of the absorption spectrum of Hematoporphyrin (Hp), between 610 and 640 nm, are currently used in photoradiation therapy (PRT) in order to maximize penetration of light into the tumor mass. Optical output powers of several watts are necessary to ensure the suitable irradiance (30÷100 mW/cm2) at the tumor surface. Filtered high-power Xenon or halogen lamps, and ion-laser-pumped dye lasers tuned at λp ≃ 630 nm are the most common sources used so far. The overall electrical-to-optical conversion efficiency of these sources is quite small, typically 0.05% (0.2 for halogen lamps). Flash-lamp-pumped dye lasers are now commercially available at average output power of 10÷ ÷20 W; the efficiency is ~ 0.8% in the red 1. Their use for photo-dynamic therapy is under investigation 2. Gold vapor lasers emitting l÷6 W at 628 nm with 0.2% efficiency represent another interesting new source for PRT of tumors 3.


Human Serum Albumin Average Output Power Superficial Tumor Diode Laser Array Wavelength Wing 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    P. Mazzinghi, P. Burlamacchi, and V. Rivano, High Efficiency, high energy slab dye laser for photobiological experiments, Submitted for publication.Google Scholar
  2. 2.
    D. A. Belenier, C. W. Lin, and J. A. Parrish, Hematoporphyrin Derivative and pulse laser photoradiation, Symposium on “Porphyrin Locialization and Treatment of Tumors”, Santa Barbara, CA, USA, April 24–28 (1983).Google Scholar
  3. 3.
    R. E. Grova, Copper vapor laser come of age, Laser Focus, 18:45 (1982).Google Scholar
  4. 4.
    E. Rossi, A. Van der Vors, and G. Jori, Competition between the singlet oxygen and electron transfer mechanisms in the porphyrin-sensitized photooxidation of L-tryptophan in acqueous micellar dispersions, Photochem. Photobiol. 34:447 (1981).Google Scholar
  5. 5.
    I. Cozzani, and J. D. Spikes, Photodamage of malignant human cells in vitro by Hematoporphyrin-visible light: possible meachanisms for photocytotoxicity, Med. Biol. Environ. 10:269 (1982).Google Scholar
  6. 6.
    J. D. Spikes, Porphyrins and related compounds as photodynamic sensitizers, Ann. N.Y. Acad. Sci. 244:496 (1975)CrossRefGoogle Scholar
  7. 7.
    E. Reddi, E. Rossi, G. Jori, L. Tomio, and B. Salvato, Photodamage of biological systems upon irradiation with He-Ne laser in the presence of Hematoporphyrin, Med. Biol. Environ. 10:251 (1982).Google Scholar
  8. 8.
    E. Reddi, F. Ricchelli, and G. Jori, Interaction of human serum albumin with Hematoporphyrin and its Zn (II) and Fe (III) derivatives, Int. J. Peptide Protein Res. 18:402 (1981).CrossRefGoogle Scholar
  9. 9.
    E. Reddi, E. Rossi, and G. Jori, Factors controlling the efficiency of porphyrins as photosensitizers of biological systems to damage by visible light, Med. Biol. Environ. 9:337 (1981).Google Scholar
  10. 10.
    T. Ormond, Fiber-optic components, EDN 28:112 (1983).Google Scholar
  11. 11.
    M. E. Mahric, M. Epstein, and R. V, Lobraico, A proposal for light-emitting diode arrays for photoradiation therapy, To be published.Google Scholar
  12. 12.
    D. R. Scifres, R. D. Burnham, C. Lindstrom, W. Streifer, and T. L. Paoli, High-power diode lasers, Paper TUC5, C.L.E.O., Baltimore, USA, May 17–20 (1983).Google Scholar

Copyright information

© Plenum Press, New York 1984

Authors and Affiliations

  • Giulio Jori
    • 1
  • Riccardo Pratesi
    • 1
    • 2
  • M. Scalvini
    • 1
    • 3
  1. 1.Istituto di Biologia AnimaleUniversità di PadovaItaly
  2. 2.Istituto di Elettronica Quantistica, CNRIstituto di Fisica Superiore dell’UniversitàFirenzeItaly
  3. 3.MASPEC - CNRParmaItaly

Personalised recommendations